Standout Papers

Incorporation of Bevacizumab... 1977 2026 1993 2009 1.6k
  1. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer (2011)
    Robert A. Burger, Mark F. Brady et al. New England Journal of Medicine
  2. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck (1988)
    André Veillette, Michael A. Bookman et al. Cell
  3. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck (1989)
    André Veillette, Michael A. Bookman et al. Nature
  4. Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup (2009)
    Michael A. Bookman, Mark F. Brady et al. Journal of Clinical Oncology
  5. Isolation and functional characterization of human intestinal mucosal lymphoid cells. (1977)
    David M. Bull, Michael A. Bookman Journal of Clinical Investigation
  6. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline (2016)
    Alexi A. Wright, Kari Bohlke et al. Journal of Clinical Oncology
  7. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline (2016)
    Alexi A. Wright, Kari Bohlke et al. Gynecologic Oncology

Immediate Impact

10 by Nobel laureates 57 from Science/Nature 84 standout
Sub-graph 1 of 16

Citing Papers

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
2017 Standout
2 intermediate papers

Works of Michael A. Bookman being referenced

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
2016 Standout
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
2009 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Michael A. Bookman 5244 3919 2596 3256 188 12.2k
Sërgio Pecorelli 4103 2852 2081 1521 177 10.3k
Robert C. Knapp 4473 1528 1528 1494 131 8.1k
Ana Oaknin 4106 6468 1689 1302 292 11.9k
Harry Hollema 1782 3958 1981 1771 226 11.6k
Carol Aghajanian 7236 5973 3112 1656 408 14.8k
Jonathan A. Ledermann 7733 8893 2958 1595 277 16.8k
Alessandro D. Santin 1937 4452 771 2304 340 10.3k
Gunnar B. Kristensen 7386 4200 3647 909 257 14.3k
Vincent T.H.B.M. Smit 3376 3655 1501 1016 192 11.6k
Robert A. Burger 8870 4510 4310 1074 200 14.4k

All Works

Loading papers...

Rankless by CCL
2026